Japanese universal health care faces a crisis in cancer treatment.

Fujiwara, Yasuhiro; Yonemori, Kan; Shibata, Taro; Okita, Natsuko; Ushirozawa, Nobuko

Fujiwara, Yasuhiro; Yonemori, Kan; Shibata, Taro; Okita, Natsuko; Ushirozawa, Nobuko.

Affiliation

Fujiwara Y; Office of Advanced Medical Care Evaluation, National Cancer Center, Tokyo, Japan; Strategic Planning Bureau, National Cancer Center, Tokyo, Japan; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan. Electronic address: yfujiwar@ncc.go.jp.
Yonemori K; Office of Advanced Medical Care Evaluation, National Cancer Center, Tokyo, Japan; Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Shibata T; Office of Advanced Medical Care Evaluation, National Cancer Center, Tokyo, Japan; Strategic Planning Bureau, National Cancer Center, Tokyo, Japan; Biostatistics Division, Center for Research Administration and Support, National Cancer Center, Tokyo, Japan.
Okita N; Office of Advanced Medical Care Evaluation, National Cancer Center, Tokyo, Japan; Department of Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
Ushirozawa N; Office of Advanced Medical Care Evaluation, National Cancer Center, Tokyo, Japan; Strategic Planning Bureau, National Cancer Center, Tokyo, Japan.

Lancet Oncol ; 16(3): 251-2, 2015 Mar.

Article in En | MEDLINE | ID: mdl-25752548

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Investigational / Universal Health Insurance / Health Policy / National Health Programs / Neoplasms / Antineoplastic Agents Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Lancet Oncol Journal subject: NEOPLASIAS Year: 2015 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google